From the Queensland Eye Institute, Brisbane, Queensland, Australia (Cronin, Gunn); Medical Affairs, Burlington, Massachusetts (Chang); Cornea Service, Wills Eye Hospital, Philadelphia, Pennsylvania (Chang).
J Cataract Refract Surg. 2024 Mar 1;50(3):209-216. doi: 10.1097/j.jcrs.0000000000001339.
To investigate the effects of customized topography-guided epithelium-on crosslinking (epi-on CXL) with oxygen supplementation on procedural efficacy and corrected distance visual acuity (CDVA) in patients with progressive keratoconus (KC) at 1 year.
Private eye clinic, Brisbane, Australia.
Retrospective, single-center, nonrandomized case series.
Topography-guided epi-on CXL using the Mosaic system was performed on patients with progressive KC. Oxygen goggles; transepithelial riboflavin; and pulsed, high UV-A irradiance (1 second on, 1 second off; 30 mW/cm2) were applied to enhance oxygen kinetics and bioavailabilities of riboflavin and UV-A. Guided by baseline topography, a higher UV-A dose (15 J/cm2) was applied to the area of steepest anterior curvature with decreasing fluence (as low as 7.2 J/cm2) toward the outer 9 mm. Postoperative CDVA and maximum keratometry (Kmax) were evaluated.
102 eyes (80 patients) were followed for 11.5 ± 4.8 months. At the latest follow-up, mean CDVA (logMAR), mean K, and Kmax (diopters [D]) improved from 0.18 ± 0.28, 46.2 ± 3.8, and 53.0 ± 5.67 at baseline to 0.07 ± 0.18, 45.8 ± 3.7, and 51.9 ± 5.56, respectively (P < .001). 3 eyes (3%) lost more than 1 CDVA line, and another 3 eyes (3%) had increased Kmax greater than 2 D. 43 eyes were followed for at least 12 months (n = 43): mean CDVA, mean K, and Kmax improved from 0.19 ± 0.33 logMAR, 46.5 ± 3.5 D, and 53.6 ± 5.67 D to 0.07 ± 0.17 logMAR, 46.0 ± 3.5 D, and 52.33 ± 5.49 D, respectively (P ≤ .002). No complications were observed.
Tailoring oxygen-supplemented epi-on CXL with differential UV-A energy distributions, guided by baseline topography, in patients with KC seems to be safe and effective. At 1 year, study reports sustained improved CDVA and corneal stabilization.
研究在渐进性圆锥角膜(KC)患者中,使用定制的基于地形图的上皮交联(epi-on CXL)联合氧补充治疗在 1 年时对手术疗效和矫正距离视力(CDVA)的影响。
澳大利亚布里斯班的私人眼科诊所。
回顾性、单中心、非随机病例系列。
使用 Mosaic 系统对进展性 KC 患者进行基于地形图的 epi-on CXL。使用氧护目镜;跨上皮核黄素;以及脉冲、高紫外-A 辐照度(1 秒开,1 秒关;30 mW/cm2),以增强氧动力学和核黄素及紫外-A 的生物利用度。根据基线地形图,在最陡的前曲率区域应用较高的紫外-A 剂量(15 J/cm2),并向外侧 9 毫米处逐渐降低光量(低至 7.2 J/cm2)。评估术后 CDVA 和最大角膜曲率(Kmax)。
102 只眼(80 例患者)随访 11.5±4.8 个月。在最近的随访中,平均 CDVA(logMAR)、平均 K 值和 Kmax(屈光度 [D])从基线时的 0.18±0.28、46.2±3.8 和 53.0±5.67 分别改善至 0.07±0.18、45.8±3.7 和 51.9±5.56(P<0.001)。3 只眼(3%)视力丧失超过 1 行,另外 3 只眼(3%)Kmax 增加超过 2 D。43 只眼至少随访 12 个月(n=43):平均 CDVA、平均 K 值和 Kmax 分别从 0.19±0.33 logMAR、46.5±3.5 D 和 53.6±5.67 D 改善至 0.07±0.17 logMAR、46.0±3.5 D 和 52.33±5.49 D(P≤0.002)。未观察到并发症。
在 KC 患者中,基于地形图的 epi-on CXL 联合氧补充治疗,根据基线地形图调整不同的紫外-A 能量分布,似乎是安全有效的。1 年后,研究报告显示 CDVA 持续改善和角膜稳定。